NCT05574322

Brief Summary

This randomized controlled trial aims to explore the effect of a foot strengthening protocol on toe flexion strength, foot deformation and morphology as well as kinetics during sprinting, cutting and jumping in healthy athletes (18-40 completed years). The study consists of a 4 weeks control period, followed by 8 weeks intervention period and 4 weeks follow up

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 10, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

February 3, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1 year

First QC Date

October 3, 2022

Last Update Submit

September 13, 2024

Conditions

Keywords

Foot strengthresistance trainingkinetics,sprintingcuttingjumpingsport performance

Outcome Measures

Primary Outcomes (1)

  • maximal isometric joint flexion muscle strength MTP (in N)

    It will be measured using an ergometer composed of a 3-dimensional force sensor (Nano 25, ATI Industrial Automation, Garner, NC) during the 3 periods of the randomized controlled trial (control, intervention and follow-up) and repeatedly each week during the intervention protocol.

    Change from baseline to Week 18

Secondary Outcomes (7)

  • Foot deformity

    Change from baseline to Week 18

  • Foot posture

    Change from baseline to Week 18

  • Morphology of the foot muscles

    Change from baseline to Week 18

  • general stiffness of the foot-ankle complex

    Change from baseline to Week 18

  • propulsion impulse during sprinting

    Change from baseline to Week 18

  • +2 more secondary outcomes

Study Arms (2)

Training group (PRP)

EXPERIMENTAL

Participants benefiting from an 8-week muscle strengthening program (PRP)

Other: Progressive foot strengthening protocol

Control group

SHAM COMPARATOR

Participants in the control group will be asked to maintain their habits and lifestyle (without training program) for the duration of the study.

Other: Control group

Interventions

This interventional group will perform the foot strengthening protocol (PRP) with physical tests as : * Maximum muscle strength of the foot * Foot muscle morphology

Training group (PRP)

The control group will not perform the foot strengthening protocol and will continue with all their daily activities with no change in lifestyle.

Control group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • To be affiliated in the federation of one of the following sports : soccer, handball, rugby, basketball or track and field;
  • To practice their respective sport more than two times per week;
  • Be affiliated or beneficiary of a social security insurance;
  • Having freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved.
  • Licensed in a tennis club (FFT) and in a volleyball club (FFVolley)

You may not qualify if:

  • Use of pharmacological therapy to match gander identity;
  • Have an abnormal range of motion of the toes and/or ankle;
  • Have any kind of ankle or foot pain (self-defined and self-reported by the FAAM questionnaire) in the previous 6 months;
  • Have a previous injury or surgery of the lower limb in the previous 6 months;
  • Have a neurological or vestibular deficit that may affect walking or balance (lumbar-sacral radiculopathy, peripheral nerve pathology, Marfan or Eehlers-Danlos syndrome, etc.);
  • Have contraindication to neuromuscular electrical stimulation (pacemaker, seizure disorders, pregnancy);
  • Have a previous foot strengthening experience in the past 6 months for at least 2 weeks and more than one session per week;
  • Participate at the same time in another medical interventional experiment or have participated in such a study in the 30 days preceding this study;
  • Being unable to understand the purpose and conditions of the study, and to give consent;
  • Being deprived of liberty or under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Pascal EDOUARD, PhD

    Centre Hospitalier Universitaire de Saint Etienne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The RCT is divided into 3 distinct periods (see study diagram in Appendix 1): a 4-week control period, an 8-week intervention period and a 4-week follow-up period. This 3-period experimental design was designed to was designed to reduce various methodological biases
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a single-center randomized controlled trial (RCT) in 2 parallel groups of athletic participants (18-40 years) in good general health: one receiving an 8-week muscle strengthening program (PRP group), the other not (control group) strengthening program (PRP group), the other not (control group).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2022

First Posted

October 10, 2022

Study Start

February 3, 2023

Primary Completion

February 14, 2024

Study Completion

June 13, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations